Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARα and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways

Journal of Cellular Biochemistry

Volumn 97, Issue 2, 2006, Pages 327-350

  Hughes, Philip J ^a   Zhao, Yi ^b   Chandraratna, Roshantha A ^b   Brown, Geoffrey ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ALLERGAN INC   (United States)

Author keywords

Genomic and non genomic signaling; Myeloid cells; Retinoid receptors; Steroid sulfatase

Indexed keywords

ALITRETINOIN; HETERODIMER; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE D; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOID; RETINOID X RECEPTOR; STERYL SULFATASE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; BONE MARROW CULTURE; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; TIME;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; MAP KINASE SIGNALING SYSTEM; PHOSPHOLIPASE D; PROTEIN KINASES; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; STERYL-SULFATASE; TRANSFECTION; TRETINOIN;

EID: 31544470332     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20579     Document Type: Article

References (124)

1. Allegretto E, McClurg M, Lazarchik S, Clemm D, Kerner S, Elgort M, Boehm M, White S, Pike J, Heyman R. 1993. Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. J Biol Chem 268:26625-26633.
2. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, Lemotte P, Pirson W, Klaus M. 1992. A retinoic acid receptor α antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA 89:7129-7133.
3. Apfel C, Kamber M, Klaus M, Mohr P, Keidel S, LeMotte P. 1995. Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor. J Biol Chem 270:30765-30772.
4. Arcaro A, Wyman M. 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor. Role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. J Biochem 296:297-301.
5. Bae Y, Lee T, Park J, Hur J, Kim Y, Heo K, Kwak J, Suh P, Ryu S. 2003. Identification of a compound that directly stimulated phospholipase C activity. Mol Pharmacol 63:1043-1050.
6. Baier R, Bondeva T, Klinger R, Bondev A, Wetzger R. 1999. Retinoic acid induces selective expression of phosphoinositide kinase γ in myelomonocytic U937 cells. 10:447-456.
7. Balasubramanian S, Chandraratna R, Eckert R. 2004. Suppression of human pancreatic cancer cell proliferation by AGN194202, an RXR-selective retinoid. Carcinogenesis 25:1377-1385.
8. Ballif B, Shimamura A, Pae E, Blenis J. 2001. Disruption of 3-phosphoinositide-dependent kinase 1 (PDK1) signalling by the anti-tumorigenic and anti-proliferative agent N-α-tosyl-L-phenylalanine chloromethyl ketone. J Biol Chem 276:12466-12475.
9. Balmer J, Blomhoff R. 2002. Gene expression regulation by retinoic acid. J Lipid Res 43:1773-1808.
10. Bastien J, Rochette-Egly C. 2004. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328:1-16.
11. Batista E, Warbington M, Badwey J, Van Dyke T. 2004. Differentiation of HL-60 cells to granulocytes involves regulation of select diacyglycerol kinases (DGKs). J Cell Biochem 94:774-793.
12. Battle T, Roberson M, Zhang T, Varayanis S, Yen A. 2001. Retinoic acid-induced blr2 expression requires RARα, RXR and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation. Eur J Cell Biol 80:59-67.
13. Beard R, Gil D, Marler D, Henry E, Colon D, Gillett S, Arefieg T, Breen T, Krauss H, Davies P, Chandraratna R. 1994. Structural basis for the differential RXR and RAR activity of stilbene retinoid analogs. Bioorg Med Chem Letts 4:1447-1452.
14. Bertagnolo V, Neri L, Marchisio M, Mischiati C, Capitani S. 1999. Phosphoinositide 3-kinase activity is essential for all-trans-retinoic acid-induced granulocytic differentiation of HL-60 cells. Canc Res 59:542-546.
15. Bertagnolo V, Brugnoli F, Marchisio M, Celeghini C, Carini C, Capitani S. 2004. Association of PI 3-K with tyrosine phosphorylated VAV is essential for its activity in neutrophil-like maturation of myeloid cells. Cell Signal 16:423-433.
16. L up-regulation. Leukaemia 17:379-389.
17. Bost F, Caron L, Marchetti I, Dani C, Marchand-Brustel Y, Binetruy B. 2002. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem J 361:621-627.
18. Botling J, Castro D, Oberg F, Nilsson K, Perlmann T. 1997. Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation. J Biol Chem 272:9443-9449.
19. Brooks S, Kazmer S, Levin A, Yen A. 1996. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X-receptor-selective retinoic acid analogs. Blood 87:227-237.
20. Cambien B, Millet M-A, Schmid-Antomarchi H, Brosette N, Rossi B, Schmid-Alliana A. 1999. Src-regulated extracellular-regulated kinase and syk-regulated c-jun N-terminal kinase pathways act in conjunction to induce IL-1 synthesis in response to microtubule disruption in HL60 cells. J Immunol 163:5079-5085.
21. Canon E, Cosagaya J, Scsucova S, Aranda A. 2004. Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells. Mol Biol Cell 15:5583-5592.
22. Carter C. 2003. Retinoic acid signalling through PI 3-kinase induces differentiation of human endometrial adenocarcinoma cells. Exp Mol Pathol 75:34-44.
23. Chen W, Thiboutot D, Zoublis C. 2002. Cutaneous androgen metabolism: Basic research and clinical perspectives. J Invest Dermatol 119:992-1007.
24. Cho Y, Talmage D. 2001. Protein kinase Cα expression confers retinoic acid sensitivity on MDA-MB-231 human breast cancer cells. Exp Cell Res 10:97-109.
25. Chu P, Cheung W, Kwong Y. 2003. Differential effects of 9-cis, 13-cis and all-trans retinoic acid in the neuronal differentiation of human neuroblastoma cells. Neuroreport 14:1935-1939.
26. Chun K, Kosmeder J, Sun S, Pezzuto J, Lotan R, Hong W, Lee H. 2003. Effects of deguelin on the phosphatidylinositol 3-kinase /Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J Natl Canc Inst 95:291-302.
27. Cosma M, Pepe S, Annunziata I, Newbold R, Grompe M, Parenti G, Ballabio A. 2003. The multiple sulphatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases. Cell 113:445-456.
28. Cosma M, Pepe S, Parenti G, Settembre C, Annunziata I, Wade-Martins R, Di Domenico C, Di Natale P, Mankad A, Cox B, Uziel G, Mancini G, Zammarchi E, Donati M, Kleijer W, Filocama M, Carozzo R, Carella M, Ballabio A. 2004. Molecular and functional analysis of SUMF1 mutations in multiple sulphatase deficiency. Hum Mut 23:576-581.
29. Davies S, Reddy H, Caivano M, Cohen P. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105.
30. Dawson M, Elstner E, Kazaki M, Chen D, Pakkala S, Kerner B, Koeffler H. 1994. Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. Blood 84:446-452.
31. Daynes R, Araneo B, Dowell T, Huang K, Dudley D. 1990. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T-helper function. J Exp Med 171:979-996.
32. De The H, Marchio A, Tiolais P, Dejean A. 1989. Differential expression and ligand regulation of the retinoic acid receptor α and β genes. EMBO J 8:429-433.
33. Delmotte M-H, Tahayato A, Formstecher P, Lefebvre P. 1999. Serine 157, a retinoic receptor α residue phosphorylated by protein kinase C in vitro, is involved in RXR-RARα heterodimerization and transcriptional activity. J Biol Chem 274:38225-38231.
34. Dierks T, Schmidt B, Borissenko L, Peng J, Preusser A, Mariappan M, Von Figura K. 2003. Multiple sulphatase deficiency is caused by mutations in the gene encoding the human Cα-formylglycine generating enzyme. Cell 113:435-444.
35. Edmunds J, Mahadevan L. 2004. MAP kinases as structural adaptors and enzymatic activators in transcription complexes. J Cell Sci 117:3715-3723.
36. El Marjou M, Montalescot V, Buzyn A, Geny B. 2000. Modification in phospholipase D activity and isoform expression occur upon maturation and differentiation in vivo and in vitro in human myeloid cells. Leukaemia 14:2118-2127.
37. Elias P, Crumrine D, Rassner U, Hachem J, Menon G, Man W, Choy M, Leypoldt L, Feingold K, Williams M. 2004. Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol 122:314-319.
38. Fanjul A, Delia D, Pierotti M, Rideout D, Yu J, Pfahl M, Qiu J. 1996. 4-hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J Biol Chem 271:22441-22446.
39. 3 and retinoic acid. Internal. J Biochem Cell Biol 37:427-441.
40. Gaub M, Lutz Y, Ruberte E, Petkovich M, Brand N, Chambon P. 1989. Antibodies specific to the retinoic acid receptors α and β. Proc Natl Acad Sci USA 86:3089-3093.
41. Geny B, Cost H, Barreau P, Basset M, Le Peuch C, Abita J, Cockcroft S. 1991. The differentiating agent, retinoic acid, causes an early inhibition of inositol lipid-specific phospholipase C activity in HL-60 cells. Cell Signal 3:11-23.
42. Germain P, Iyer J, Zechel C, Gronemeyer H. 2002. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415:187-192.
43. Gianni M, Li Calzi M, Terao M, Guiso G, Caccia S, Barbui T, Rambaldi A, Garattini E. 1996. AM580, a stable benzoic derivative of retinoic acid, has a powerful and selective cyto-differentiating effect on promyelocytic cells. Blood 87:1520-1531.
44. Glasow A, Prodromou N, Xu K, Von Lindern M, Zelent A. 2005. Retinoids and myelomonocytic growth factors cooperatively activate RARα and induce human myeloid leukaemia cell differentiation via MAP kinase pathways. Blood 105:341-349.
45. Griffiths G, Garrone B, Deacon E, Owen P, Pongracz J, Mead G, Bradwell A, Watters D, Lord J. 1996. The polyether Bistratene A activated protein kinase C-δ and induces growth arrest in HL60 cells. Biochem Biophys Res Commun 22:802-808.
46. Hanson S, Best M, Wong C-H. 2004. Sulfatases: Structure, mechanism, biological activity, inhibition and synthetic utility. Angew Chem Int Ed 43:5736-5763.
47. Hashimoto Y, Petkovich M, Gaub M, Kagechika H, Shudo K, Chambon P. 1989. The retinoic acid receptors α and β are expressed in the human promyelocytic leukaemia cell line HL-60. Mol Endocrinol 3:1046-1052.
48. Hashimoto Y, Kagechika H, Shudo K. 1990. Expression of retinoic acid receptor genes and the ligand-binding selectivity of retinoic acid receptors (RAR's). Biochem Biophys Res Commun 166:1300-1307.
49. Heyman R, Mangelsdorf D, Dyck J, Stein R, Eichele G, Evans R, Thaller C. 1992. 9-cis-retinoic acid is a high affinity ligand for the retinoid-X receptor. Cell 68:397-406.
50. Hida T, Tai K, Tokuhara N, Ishibashi A, Kikuchi K, Hibi S, Yoshimura H, Nagai M, Yamauchi T, Kobayashi S. 2001. Existence of retinoic acid receptor-independent retinoid X-receptor-dependent pathway in myeloid cell function. Jpn J Pharmacol 85:60-69.
51. Hong H, Varvayanis S, Yen A. 2001. Retinoic acid causes MEK-dependent RAF phosphorylation through RARα plus RXR activation in HL-60 cells. Differentiation 68:55-66.
52. 3. Biochem J 365:361-371.
53. Iirie T, Homma Y, Ohaka Y, Robishaw J, Katada T, Bourne H. 1995. Potentiation of Gi-mediated phospholipase C activation by retinoic acid in HL-60 cells. Possible role of Gγ2. J Biol Chem 270:5901-5908.
54. Ijpenberg A, Tan A, Gelman L, Kersten S, Seydoux J, Xu J, Metzger D, Canaple L, Chambon P, Wahl W, Desvergne B. 2004. In vivo activation of PPAR target genes by RXR homodimers. EMBO J 23:2083-2091.
55. Ishida S, Shigemoto-Mogami Y, Shinozaki Y, Kagechika H, Shudo K, Ozawa S, Sawada J-I, Ohno Y, Inoue K. 2004. Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and AM580-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol 68:2177-2186.
56. Ishii Y, Sakai S, Honma Y. 2001. Pyridinyl imidazole inhibitor SB203580 activates p44/p42 mitogen-activated protein kinase and induces differentation of human myeloid leukaemia cells. Leuk Res 25:813-820.
57. Kambhampati S, Li Y, Verma A, Sassano A, Majchrzak B, Deb D, Parmar S, Giafis N, Kalvakolanu D, Rahman A, Uddin S, Minucci S, Tallman M, Fish E, Platanias L. 2003. Activation of protein kinase Cδ by all-trans-retinoic acid. J Biol Chem 278:32541-32551.
58. Kanaho Y, Nakai Y, Katoh M, Nozawa Y. 1993. The phospholipase inhibitor 2,3-diphosphoglycerate interferes with phospholipase D activation in rabbit neutrophils. J Biol Chem 268:1249-12497.
59. Kizaki M, Ikeda Y, Tanosaki R, Nakajima H, Morikawa M, Sakashita A, Koeffler H. 1993. Effects of novel retinoic acid compound 9-cis-retinoic acid, on proliferation, differentiation and expression of retinoic acid-α and retinoid X receptor-α RNA by HL60 cells. Blood 82:3592-3599.
60. Kizaki M, Dawson M, Heyman R, Elster E, Morosetti R, Pakkala S, Chen D, Ueno H, Chao W, Morikawa M, Ikeda Y, Heber D, Pfahl D, Koeffler H. 1996. Effects of novel retinoid X receptor-selective ligands can induce myeloid leukaemia differentiation and proliferation in vitro. Blood 87:1977-1984.
61. Kozikowski A, Sun H, Brignard J, Dennis P. 2003. Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt. J Am Chem Soc 125:1144-1145.
62. Krjukova J, Holmqvist T, Danis A, Akerman K, Kukkonen J. 2004. Phospholipase C activator m-3M3FBS affects Ca2+ homeostasis independently of phospholipase C activation. Br J Pharmacol 143:3-7.
63. Kulp S, Yang Y, Hung C, Chen K, Lai J, Tseng P, Fowble J, Ward P, Chen C. 2004. 3-phosphoinositide-dependent protein kinase-1/Akt signals represents a major cyclooxygenase-2-independent targets for celecoxib in prostate cancer cells. 64:1444-1451.
64. Lal L, Li Y, Smith J, Sassano A, Uddin S, Parmar S, Tallman M, Minucci S, Hay N, Platanias L. 2005. Activation of the p70 S6 kinase by all-trans-retinoic acid in acute promyelocytic leukaemia cells. Blood 105:1669-1677.
65. Leontieva O, Black J. 2004. Identification of two distinct pathways of protein kinase Cα down-regulation in intestinal epithelial cells. 279:5788-5801.
66. Lewandowski D, Linassier C, Iochman S, Degenne M, Domench J, Colombat P, Binet C, Herault O. 2002. Phosphatidylinositol 3-kinases are involved in all-trans retinoic acid-induced upregulation of CD38 antigen on human haematopoietic cells. Br J Haematol 118:535-544.
67. Li X, Li H, Xiao Z, Piao Y. 2002. Divergent effects of retinoic acids on the expression of ERα and 17β-hydroxysteroid dehydrogenase type 1 in endometrial carcinoma cells (RL 95-2). J Clin Endocrinol Metab 87:640-649.
68. Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D. 2002. Activation of the phosphatidylinositol 3-kinase/Akt signalling pathway by retinoic acid is required for neural differentiation of SH-SYU5Y human neuroblastoma cells. 277:25297-25304.
69. Lopez-Pedrera C, Dobado-Berrios P, Ros R, Torres A, Garcia-Navarro S, Jardi M, Felez J, Velasco F. 2001. Signal transduction pathways underlying the expression of tissue factor and thrombomodulin in promyelocytic cells induced to differentiate by retinoic acid and dibutyrl camp. Thromb Haemost 85:1031-1036.
70. Lopez-Pedrera C, Barbarroja N, Buendia P, Torres A, Dorada G, Velasco F. 2004. Promyelocytic leukemia retinoid signalling targets regulate apoptosis, tissue factor and thrombomodulin expression. Haematologica 89:286-295.
71. Mansfield P, Carey S, Hinkovska-Galcheva V, Shayman J, Boxer L. 2004. Ceramide inhibition of phospholipase D and its relationship to RhoA and ARF1 translocation in GTPγS-stimulated polymorphonuclear leukocytes. Blood 103:2363-2368.
72. 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem Biophys Res Commun 241:419-426.
73. Martelli A, Tazzari P, Tabelini G, Bortul R, Billi A, Manzoli L, Ruggeri A, Conte R, Cocco L. 2003. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionising radiation of human leukaemia cells. Leuk 17:1794-1805.
74. Metha K, McQueen T, Manshouri T, Andreef M, Collins S, Aibtar M. 1997. Involvement of retinoic acid receptor-alpha-mediated signalling pathway in the induction of CD38 cell surface antigen. Blood 89:3607-3614.
75. Miguel B, Calcerrade M, Mata F, Aller P, Clemente R, Catalan R, Martinez A. 2000. Differential redistribution of protein kinase C isoforms by cyclic AMP in HL60 cells. Biochem Biophys Res Commun 274:596-602.
76. Miloso M, Villa D, Crimi M, Galbiati S, Donzelli E, Nicolini G, Tredici G. 2004. Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent. J Neurosci Res 75:241-252.
77. Miranda M, McGuire T, Johnson D. 2002. Importance of MEK-1/-2 signalling in monocytic and granulocytic differentiation of myeloid cell lines. Leukaemia 16:683-692.
78. Mountford J, Bunce C, Hughes S, Drayson M, Webb D, Hewison M. 1999. Estrone potentiates myeloid cell differentiation a role for 17β- hydroxysteroid dehydrogenase in modulating hemopoiesis. Exp Haematol 27:451-460.
79. Mu Y, Yanase T, Nishi Y, Hirase N, Goto K, Takayanagi R, Nawata H. 2000. A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells. Mol Cell Endocrinol 166:137-145.
80. Nagpal S, Athanikar J, Chandraratna R. 1995. Separation of transactivation and API antagonism functions of retinoic acid receptor α. J Biol Chem 270:923-927.
81. Nagy L, Thomazy V, Shipley G, Fesus L, Lamph W, Heyman R, Chandraratna R, SNM〉 S P. 1995. Activation of retinoid X receptors induces apoptosis in myeloid cell lines. Mol Cell Biol 15:3540-3551.
82. Nakashima S, Ohguchi K, Frohman M, Nozawa Y. 1998. Increased mRNA expression of phospholipase D (PLD) isoenzymes during granulocytic differentiation of HL60 cells. Biochim Biophys Acta 1389:173-177.
83. Nakashima S, Iwasaki Y, Mizutani T, Ohuguchi K, Nagata K, Kitajima Y, Nozawa Y. 1996. Differential expression of protein kinase C isozymes and small FTP-binding proteins during HC-60 differentiation by retinoic acid and cyclic AMP: relation with phospholipase D (PLD) activation. Immunobiology 196:588-598.
84. Neri L, Bortul R, Borgatti P, Tabellini G, Baldini G, Capitani S, Martelli A. 2002. Proliferating or differentiating stimuli act on different lipid-dependent signalling pathways in nuclei of human leukaemia cells. Mol Biol Cell 13:947-964.
85. Nervi C, Grippo J, Sherman M, George M, Jetten A. 1989. Identification and characterisation of nuclear retinoic acid-binding activity in human myeloblastic leukaemia HL-60 cells. Proc Natl Acad Sci 86:5854-5858.
86. Newman S, Purohit A, Ghilchik M, Potter B, Reed M. 2000. Regulation of steroid sulphatase expression and activity in breast cancer. J Ster Biochem Mol Biol 31:259-264.
87. Ng J-H, Nesaretnam K, Reiman K, Lai L. 2000. Effect of retinoic acid and palm oil carotenoids on oestrone sulphatase and oestradiol-17β hydroxysteroid dehydrogenase activities in MCF-7 and MDA-MB-231 breast cancer cell lines. Int J Cancer 88:135-138.
88. Nussbaumer P, Billich A. 2004. Steroid sulphatase inhibitors. Med Res Rev 24:529-576.
89. Ohoka Y, Kontani K, Iirie T, Nishana H, Katada T. 1995. Involvement of pertussis toxin-sensitive mechanism in retinoic acid-induced differentiation of human leukaemic HL-60 cells. J Biochem 117:190-196.
90. Ozpolat B, Tari A, Mehta K, Lopez-Berestein G. 2004. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl)retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukaemia cells. Leuk Lymphoma 45:979-985.
91. Pendino F, Dudognon C, Delhommeau F, Sahraoui T, Flexor M, Bennaceur-Griscelli A, Lanotte M, Segal-Bendirdjian E. 2003. Retinoic acid receptor α and retinoid-X receptor agonists synergistically target telomerase expression and induce tumor cell death. Oncogene 22:9142-9150.
92. Piao Y, Peltoketo H, Jouppila A, Vihko R. 1997. Retinoic acids increase 17β-hydroxysteroid dehydrogenase type 1 expression in JEG-3 and T47D cells, but the stimulation is potentiated by epidermal growth factor, 12-O-tetradecanoylphorbol-13-acetate, and cyclic adenosine monophosphate only in JEG-3 cells. Endocrinology 138:898-904.
93. Porfiri E, Hoffbrand A, Wickremasinghe R. 1991. Retinoic-acid granulocytic differentiation of HL60 human promyelocytic leukaemia cells is preceded by downregulation of autonomous generation of inositol lipid-derived second messengers. Blood 78:1069-1077.
94. Qin S, Yamamura H. 1997. Up-regulation of Syk activity during HL60 cell differentiation into granulocyte but not into monocyte/macrophage-lineage. Biochem Biophys Res Commun 236:697-701.
95. Rabano M, Pena A, Brizuela L, Macarulla J, Gomez-Munoz A, Trueba M. 2004. Angiotensin II-stimulated cortisol secretion is mediated by phospholipase D. Mol Cell Endocrinol 222:9-20.
96. Radominska-Pandya A, Chen G. 2002. Photoaffinity labelling of human retinoid X receptor-β (RXRβ) with 9-cis-retinoic acid: identification of phytanic acid, docosahexanoic acid and lithocholic acid as ligands of RXRβ. J Biochem 41:4883-4890.
97. Reed M, Rea D, Duncan L, Parker M. 1994. Regulation of estradiol 17β-hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells. Endocrinol 135:4-9.
98. Reed M, Purohit A, Woo L, Newman S, Potter B. 2004. Steroid sulphatase: Molecular biology, regulation and inhibition. Endocr Rev 26:171-202.
99. Robertson K, Emami B, Collins S. 1992. Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain confers dominant negative activity. Blood 80:1885-1889.
100. Ross S, McCafery P, Drager U, De Luca L. 2000. Retinoids in embryonal development. Physiol Rev 80:1021-1054.
101. Roy B, Taneja R, Chambon P. 1995. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by RA receptor α (RARα)-, RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol Cell Biol 15:6461-6487.
102. + erythroid progenitor cells. Blood 87:1728-1736.
103. Sato S, Fujita N, Tsuruo T. 2002. Interference with PDK1-Akt survival signalling pathway by UCN-01 (7-hydroxystaurosporine). Oncogene 21:1727-1738.
104. Slosberg E, Yao Y, Xing F, Ikui A, Jirousek M, Weinstein I. 2000. The protein kinase Cb-specific inhibitor LY379296 blocks TPA-induced monocytic differentiation of HL60 cells. Mol Carcinog 27:166-176.
105. Soprano D, Qin P, Soprano K. 2004. Retinoic acid receptors and cancer. Ann Rev Nutr 24:201-221.
106. Szondy Z, Reichert U, Bernardon J, Michel S, Toth R, Karaszi E, Fesus L. 2001. Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated by retinoid receptor-alpha. Biochem J 331:767-774.
107. Tocci A, Parolini I, Gabbianelli M, Testa U, Luchetti L, Samoggia P, Massella B, Russo G, Valtieri M, Peschle C. 1996. Dual action of retinoic acid on human embryonic/fetal hematopoiesis: Blockade of primitive progenitor proliferation and shift from multipotent/erythroid/monocytic to granulocytic differentiation program. Blood 88:2878-2888.
108. Tsai S, Collins S. 1993. A dominant negative retinoic acid receptor blocks differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90:7153-7157.
109. Vara J, Casado E, De Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M. 2004. PI3K/Akt signalling pathway and cancer. Canc Treatment Revs 30:193-204.
110. Vlahos C, Matter W, Hui K, Brown R. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248.
111. Vuligonda V, Thacher S, Chandraratna R. 2001. Enantioselective synthesis of potent retinoid X receptor ligands: Differential biological activities of individual antipodes. J Med Chem 44:2298-2303.
112. 3-in differentiation of HL60 cells. J Cell Biochem 80:471-482.
113. Wang X, Studzinski G. 2001b. Phosphorylation of Raf-1 by kinase suppessor of Ras is inhibited by "MEK-specific" inhibitors PD 098059 and U1026 in differentiating HL60 cells. Exp Cell Res 268:294-300.
114. Wang J, Yen A. 2004. A novel retinoic acid-responsive element regulated retinoic acid-induced BLR1 expression. Mol Cell Biol 24:2423-2443.
115. 3. J Cell Biochem 89:1087-1101.
116. Witcher M, Ross D, Rosseau C, DeLuca L, Miller W. 2003. Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukaemia cells. Blood 102:237-245.
117. Yanase T, Mu Y-M, Nishi Y, Goto K, Nomura M, Okabe T, Takayanagi R, Nawata H. 2001. Regulation of aromatase by nuclear receptors. J Steroid Biochem Molec Biol 79:1870192.
118. Yang C, Kazanietz M. 2003. Divergence and complexities in DAG signalling: Looking beyond PKC. Trends Pharm Sci 24:602-608.
119. Yang S-H, Sharrocks A, Whitmarch A. 2003. Transcriptional regulation by the MAP kinase signalling cascades. Gene 320:3-21.
120. Yen A, Roberson M, Varvayanis S. 1999. Retinoic acid selectively activates the ERK2 but not JNK or p38 MAP kinases when inducing myeloid differentiation. In Vitro Cell Dev Biol Anim 35:527-532.
121. Yen A, Fenning R, Chandraratna R, Walker P, Varvayanis S. 2004. A RARβ/γ selective prodrug (Tazarotene) plus RXR ligand induces ERK activation, RB hypophosphorylation, G0 arrest and cell differentiation. Mol Pharm 66:1727-1737.
122. Zhang J, Zhuang W, Poon K, Yang M, Fong W. 2003. Induction of HL-60 cell differentiation by the p38 mitogen-activate protein kinase inhibitor SB203580 is mediated through the extracellular signal-regulated kinase signalling pathway. Anticanc Drugs 14:31-38.
123. Zhao K-W, Li X, Zhao Q, Huang Y, Li D, Peng Z-G, Shen W-Z, Zhao J, Zhou Q, Chen Z, Sims P, Wiedmer T, Chen G-Q. 2004. Protein kinase Cδ mediates retinoic acid and phorbol nyristate aceteate-induced phospholipid scramblase I gene expression: Its role in leukaemic cell differentiation. Blood 104:3731-3738.
124. Zhu S, Li Y, Wang Y, Xiao Z, Vihko P, Piao Y. 2002. Retinoic acids promote the action of aromatase and 17β hydroxysteroid dehydrogenase type 1 on the biosynthesis of 17β-estradiol in placental cells. J Endocrinol 172:31-43.